ABVC BioPharma, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $7.4M | $2.7M |
| Jun 2022 | — | $9.3M | $2.9M |
| Sep 2022 | — | $5.9M | $1.3M |
| Dec 2022 | — | $3.1M | $85.3K |
| Mar 2023 | — | $1.7M | $1.1M |
| Jun 2023 | — | $-379.3K | $99.3K |
| Sep 2023 | — | $9.1M | $500.1K |
| Dec 2023 | — | $1.6M | $60.2K |
| Mar 2024 | — | $1.7M | $30.5K |
| Jun 2024 | — | $1.8M | $124.3K |
| Sep 2024 | — | $1.6M | $137.3K |
| Dec 2024 | — | $1.2M | $248.4K |
| Mar 2025 | — | $5.4M | $152.2K |
| Jun 2025 | — | $7.0M | $388.3K |
| Sep 2025 | — | $12.1M | $192.1K |
| Dec 2025 | — | $11.1M | $681.5K |
| Mar 2026 | — | $10.8M | $140.3K |
| Jun 2026 | — | $10.3M | $31.9K |